Nissha Co., Ltd.
Notice Regarding Acquisition of Shares (Subsidiarization) of Vietnamese Medical Device Manufacturer USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY
NISSHA Co., Ltd. decided on January 23, 2026, to acquire 60% of the shares of Vietnamese medical device manufacturer USM Healthcare and make it a subsidiary. The acquisition price is undisclosed, with the transfer scheduled for March 2026.
Key Figures
- Number of Shares Acquired: 16,960,877 shares (equivalent number of voting rights)
- USM Healthcare Consolidated Net Sales (Fiscal Year Ending December 2024): 321,909 million Vietnamese Dong
- USM Healthcare Net Income (Fiscal Year Ending December 2024): 1,480 million Vietnamese Dong
AI要約
Overview of the M&A
At the board meeting held on January 23, 2026, NISSHA Co., Ltd. decided to acquire 60% of the shares of USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY, a medical device manufacturer based in Ho Chi Minh City, Vietnam, making it a subsidiary. USM Healthcare manufactures and sells stents for cardiology and orthopedic devices, achieving vertical integration from product design to manufacturing and sales. It is growing as the only domestic stent manufacturer in Vietnam and also operates a medical device CDMO business. The acquisition price is undisclosed but has been reasonably calculated using the DCF method by a third-party organization.
Future Outlook and Impact
Through this acquisition, NISSHA will establish a business foundation for medical device manufacturing in the Asian region and aims to expand its business by linking with its existing customer bases in the United States and Japan. Against the backdrop of the rapidly expanding medical device market in Southeast Asia, the company plans to promote geographic expansion of its medical device CDMO business. The impact on consolidated financial results is expected to be minimal. The share transfer is scheduled to be executed in March 2026.
